▲ Peaking
Health
New Injection Reduces Belly Fat Without Major Weight Loss. Scientists Are Testing What Happens Next
MarketScreener lists a TWD 240.00 target for Caliway Biopharmaceuticals C stock amid ongoing medical developments.
Twd
1 trends tracked about this subject — the full history, oldest to newest below.